|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the EYE 8-K filed Jun 6, 2006. Quest Vision Technology, Inc. (Quest) In June 2005, the Company acquired Quest, an optical medical device research and development company, for approximately $2.5 million. Approximately $2.3 million of the purchase price was expensed as IPR&D in the year ended December 31, 2005, as it represents the estimated fair value of projects that had not reached technological feasibility and had no alternative future use at the date of acquisition. The acquisition of Quest was not material to the historical consolidated financial position, results of operations or cash flows of the Company. This excerpt taken from the EYE 10-Q filed Nov 8, 2005. Quest Vision Technology, Inc. (Quest)
In June 2005, the Company acquired Quest, an optical medical device research and development company, for approximately $2.5 million. Approximately $2.3 million of the purchase price was expensed as IPR&D in the nine months ended September 30, 2005, as it represents the estimated fair value of projects that had not reached technological feasibility and had no alternative future use at the date of acquisition. The acquisition of Quest was not material to the historical consolidated financial position, results of operations or cash flows of the Company.
Note 3: Composition of Certain Financial Statement Captions
The components of inventories were as follows:
The components of amortizable intangibles and goodwill were as follows:
This excerpt taken from the EYE 10-Q filed Aug 1, 2005. Quest Vision Technology, Inc. (Quest)
In June 2005, the Company acquired Quest, an optical medical device research and development company, for approximately $2.5 million. Approximately $2.3 million of the purchase price was expensed as IPR&D in the three months ended June 24, 2005, as it represents the estimated fair value of projects that had not reached technological feasibility and had no alternative future use at the date of acquisition. The acquisition of Quest was not material to the historical consolidated financial position, results of operations or cash flows of the Company.
10
Table of ContentsAdvanced Medical Optics, Inc. Notes to Unaudited Condensed Consolidated Financial Statements
Note 3: Composition of Certain Financial Statement Captions
The components of inventories were as follows:
The components of amortizable intangibles and goodwill were as follows:
| EXCERPTS ON THIS PAGE:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||